Gilead Sciences to Present at the NASDAQ OMX 30th Investor Program on
Tuesday, December 3
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif. -- December 2, 2013
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the NASDAQ OMX 30^th Investor Program in
Robin Washington, Gilead’s Senior Vice President and Chief Financial Officer,
will provide an overview of the company at the conference on Tuesday, December
3 at 11:45 a.m. Greenwich Mean Time (6:45 a.m. Eastern Time).
To access the live webcast or a replay via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North and South America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit www.gilead.com or call
the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Press spacebar to pause and continue. Press esc to stop.